Delivery Order SPE2DE21D7020-SPE2D625F1GDG
- Not listed
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $18,134.55 for agent drug-coated balloons by the Defense Health Agency's Medical Supply Chain on August 8, 2025. The delivery order, which carries an ultimate completion date of August 15, 2025, represents a competitive award with no set-aside designation. The contract employs fixed-price pricing with economic price adjustment mechanisms...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $8,714.55 to Boston Scientific Corp for drug-coated balloons, with performance scheduled to conclude by July 25, 2025. This fixed-price delivery order with economic price adjustment represents a competitive contract with no set-aside designation. Boston Scientific, headquartered in Marlborough, Massachusetts, will perform work at its primary facility in the same location. The contract exemplifies the ongoing...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $18,953.95 for agent drug-coated balloon supplies. The contract, awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, is funded through the Defense Health Agency's Medical Supply Chain division. This fixed-price contract with economic price adjustment represents Boston Scientific's continued role as a critical supplier...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp on August 15, 2025, for agent drug-coated balloons, with a ceiling value of $13,590.30. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 22, 2025, and will be performed at Boston Scientific's facility in Marlborough, Massachusetts. The award carries no set-aside designation, indicating open competition in the federal marketplace. Drug-coated...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $21,014.55 to Boston Scientific Corp for agent drug-coated balloons, with an ultimate completion date of July 30, 2025. This fixed-price contract with economic price adjustment was issued without a set-aside designation, allowing Boston Scientific to compete openly in the federal marketplace. The work will be performed at the company's facility in Marlborough, Massachusetts, where Boston Scientific manufactures...
- Boston Scientific Corp has been awarded a delivery order valued at $6,175.00 for agent drug-coated balloons under the Defense Health Agency's Medical Supply Chain contract vehicle. The award, issued on August 15, 2025, with an ultimate completion date of August 22, 2025, represents a fixed-price contract with economic price adjustment provisions. The work will be performed at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. This delivery order...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order to Boston Scientific Corp for agent drug-coated balloons with a ceiling value of $6,175. The contract is a fixed-price agreement with economic price adjustment provisions, with an ultimate completion date of August 21, 2025. This delivery order was not set aside for any specific business category and will be performed at Boston Scientific's Marlborough, Massachusetts facility. As a prime contractor, Boston Scientific is...
- Boston Scientific Corp has been awarded a delivery order valued at $21,828.61 for Agent Drug Coated Balloon devices under a fixed price contract with economic price adjustment provisions. The contract was awarded on July 22, 2025, by the Defense Health Agency's Medical Supply Chain and is scheduled for completion by July 29, 2025. This delivery order represents Boston Scientific's continued provision of advanced cardiovascular medical devices to federal healthcare agencies. The award is not...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order valued at $55,947.15 by the Defense Health Agency's Medical Supply Chain on July 29, 2025, with an ultimate completion date of August 5, 2025. The contract, which carries no set-aside designation, calls for the delivery of Ranger Global DCB (drug-coated balloon) devices measuring 4.0 x 120mm with a 150cm length. Performance will take place at Boston...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $13,356.93 for drug-coated balloons under a fixed-price contract with economic price adjustment provisions. The award was issued on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract was funded by the Defense Health Agency's Medical Supply Chain and represents an open competition award with no set-aside designation. Drug-coated balloons are...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F1GDGDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $26,532.60 to Boston Scientific Corp for agent drug-coated balloon medical devices. The contract, issued on August 18, 2025, carries a fixed-price pricing structure with economic price adjustment provisions and has an ultimate completion date of August 25, 2025. This delivery order represents a continuation of Boston Scientific's role as a key supplier of specialized cardiovascular intervention equipment to federal healthcare systems. The award was made without a set-aside designation, indicating open competition in the federal marketplace. Performance will be conducted at Boston Scientific's facility in Marlborough, Massachusetts, the company's headquarters location. Boston Scientific Corp is a leading global medical technology manufacturer specializing in innovative cardiovascular, interventional, and diagnostic medical devices supplied to federal agencies including the Department of Veterans Affairs and the Defense Health Agency. The company maintains a substantial portfolio of federal contracts and indefinite delivery vehicles, including a significant single-award Blanket Purchase Agreement with the Defense Health Agency valued at $750,000 through March 2030 for radiation treatment devices. Drug-coated balloons represent critical interventional cardiology tools used in angioplasty procedures, and this delivery order supports the federal government's medical supply chain requirements for advanced cardiovascular treatment capabilities across the Defense Health Agency network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 8/18/25 |